DOI: 10.36347/sajb.2021.v09i02.002

Pages: 25-28

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), initially named novel coronavirus or 2019-nCoV, is a single-stranded RNA virus. Covid has been designated as pandemic by WHO. Adaptability and mutations of the virus made the treatment modalities difficult and complications even worsen. Human to human transmission is more in crowded areas, social and mass gathering and making the virulence more and more. Patients suffering from symptoms of like fever, cough, dyspnoea, myalgia, headache, and sore throat were considered who attended the OPD of medicine and other departments. Severity of clinical symptoms can vary between individuals. 81% of cases were described as mild (i.e. non-pneumonia and mild pneumonia). 14% of cases were severe (i.e. dyspnea, respiratory frequency ≥30/min, blood oxygen saturation ≤93%, partial pressure of arterial oxygen to fraction of inspired oxygen ratio 50% within 24–48 h), and 5% were critical (i.e. respiratory failure, septic shock, and/or multiple organ dysfunction or failure). Treatment depends on the supportive and invasive methods. Preventive measures are better modalities and still holds good to decrease the spread of coronavirus which includes handwash using sanitizers, N95 masks and spacing.